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Abstract
The development of a new family of implantable bioinspired materials is a focal point of bone tissue engineering. Implant
surfaces that better mimic the natural bone extracellular matrix, a naturally nano-composite tissue, can stimulate stem cell
differentiation towards osteogenic lineages in the absence of specific chemical treatments. Herein we describe a bioactive
composite nanofibrous scaffold, composed of poly-caprolactone (PCL) and nano-sized hydroxyapatite (HA) or beta-
tricalcium phosphate (TCP), which was able to support the growth of human bone marrow mesenchymal stem cells (hMSCs)
and guide their osteogenic differentiation at the same time. Morphological and physical/chemical investigations were
carried out by scanning, transmission electron microscopy, Fourier-transform infrared (FTIR) spectroscopy, mechanical and
wettability analysis. Upon culturing hMSCs on composite nanofibers, we found that the incorporation of either HA or TCP
into the PCL nanofibers did not affect cell viability, meanwhile the presence of the mineral phase increases the activity of
alkaline phosphatase (ALP), an early marker of bone formation, and mRNA expression levels of osteoblast-related genes,
such as the Runt-related transcription factor 2 (Runx-2) and bone sialoprotein (BSP), in total absence of osteogenic
supplements. These results suggest that both the nanofibrous structure and the chemical composition of the scaffolds play
a role in regulating the osteogenic differentiation of hMSCs.
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Introduction
Regenerative medicine aims to repair and replace lost or
damaged tissues by initiating the natural regeneration process.
Current paradigms in tissue engineering often involve the
combination of mesenchymal stem/progenitor cells and the
synthesis of novel biomaterials, tailoring physical, chemical and
structural properties to mimic crucial aspects of the physiological
niche [1]. Ideally, the scaffold design is aimed at reproducing all
required signals at macro, micro- to nano-scales, respectively
corresponding to tissue, cellular, and molecular scales in a specific
tissue, in order to foster and direct cellular attachment,
proliferation, desired differentiation towards specific cell pheno-
types. In this context, several factors must be considered, such as
the chemical nature of scaffolding material, the physical structures
at various size scales, and the method of fabrication [2–6].
Several studies have indicated that the presence of a mineral
biomimetic phase, such as hydroxyapatite (HA) or tricalcium
phosphates (TCP), is important for the success of a scaffold
promoting bone regeneration [7,8]. HA is more stable, exhibiting
much lower dissolution rates, whereas beta-TCP is more soluble
and its degradation products, Ca
2+ and PO4
32, are released into
the surrounding environment, potentially inducing bioactivity
[8,9]. However, the use of either compound is hampered by
difficulties in processing into highly porous structures and native
brittleness. In contrast, many synthetic biodegradable polymers
are proposed in various tissue engineering applications, including
bone tissue repair, based on their flexibility of material properties
and the ability to support cell growth [2,10,11], but they typically
lack in osteoconductive properties. A good compromise may be
represented by composites joining polymer plasticity with the
osteoinductivity of phosphate ceramics.
Besides the chemical composition, also the micro-nano-
structural properties of the bone substitutes have to be accurately
defined, since the surface morphology, stiffness or topography of
scaffolds can directly and significantly affect cell-scaffold interac-
tions and ultimately tissue formation [3,5,12–13]. To date, a very
few studies report on hMSCs differentiated in vitro into osteogenic
[14–16], neuronal [17], or muscular [18] lineages without any
exogenous soluble differentiation factor, exploiting predetermined
micropatterns and geometries. Following a biomimetic approach,
the use of nanofibers structures would add further value in this
framework, by mimicking the intricate fibrillar architecture of
natural extracellular matrix (ECM) components. In fact, the ECM
plays an important role in regulating aspects of cell division,
adhesion, cell motility, differentiation and migration, modulating
growth factors distribution, activation, and presentation to cells
[19,20]. Therefore, the development of an artificial ECM,
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ECM, represents a promising approach. Polymer processing
technologies, such as electrospinning, allow the production of
scaffolds with a morphology characterized by a nanofibrillar
structure and have been successfully employed for tissue
engineering applications [21]. Previous studies focusing on
electrospun scaffolds for bone tissue engineering, have employed
a wide range of materials for inducing bone differentiation, but
always using osteogenic medium [22–37]. The effects related to
the use of basal or osteogenic media are rarely reported for
Polycaprolactone (PCL) scaffolds [36,37], showing no evidence of
intrinsic osteoinductive properties for the scaffold (i.e. in the
absence of osteogenic supplements).
This work describes biomimetic, bioactive composite scaffolds
and their ability to induce hMSCs towards an osteogenic
differentiation, exploiting their chemical and nano-micro topolog-
ical structure. PCL, one of the most popular synthetic polymers
approved by the US Food and Drug Administration [31–37], was
used as polymer matrix , while HA and TCP represented the
mineral phase. Our findings highlight a mature osteogenic
differentiation of hMSCs when cultured in vitro in basal growth
medium conditions onto nanofibrous ceramic-polymer materials.
An increased Alkaline Phosphatase (ALP) activity and mRNA
expression modulation of the most typical osteoblast-related genes
were observed.
Materials and Methods
Scaffolds fabrication
PCL powders (Mw 70,000–90,000, Sigma-Aldrich, St. Louis,
MO) was dissolved in hexafluoroisopropanol (HFIP, Carlo Erba,
Milan, Italy) under stirring for a few hours, obtaining a 3.5%
concentration. For composite fibers, HA (average size 20–70 nm)
or beta-TCP (average size 100 nm) nanocrystals (Berkeley
Advanced Biomaterials, San Leandro, CA) were added to the
PCL/HFIP solution and put under stirring for one week, using
oleic acid (0.05% w/v) as surfactant in order to obtain stable
particle suspension in the polymer solution [32]. Three different
solutions were prepared: 3.5% PCL, 3.5%–2% PCL-HA, 3.5%–
2% PCL-TCP using HFIP as solvent (all the concentrations are
expressed as w/w ratios in relation to the solution). For the
electrospinning process, each polymer solution was loaded in a
plastic syringe with a 27 gauge stainless steel needle, and a 4.5 kV
voltage was applied using a high voltage power supply (EL60R0.6–
22, Glassman High Voltage, High Bridge, NJ). The injection flow
rate was fixed at 0.5 mL/h, supplied by a microfluidic syringe
pump (Harvard Apparatus, Holliston, MA). The nanofibers (NFs)
were collected on round (diameter 15 mm) or rectangular
(75625 mm
2) borosilicate glass coverslips, mounted on a ground-
ed 10610 cm
2 collector at a distance of 20 cm from the needle, for
2 hs. The air relative humidity and temperature conditions were
about 40% and 23uC, respectively. As control, the same
electrospinning solutions were employed for obtaining film
samples by spin coating (5000 rpm for 60 sec). All the samples
were stored in a vacuum desiccator at room temperature for at
least one week, to remove any residual HFIP molecule. At the end
of the procedure, six different scaffolds were available: PCL, PCL-
HA and PCL-TCP, both in the nanofibrous structure and film. All
samples were sterilized by gamma-irradiation (5000 rad) before
cell culture.
Scaffolds characterization
The morphology of nanofibrous samples was analyzed by
electron microscopy. For scanning electron microscopy (SEM),
NFs were imaged by a Raith 150 system (Raith, Dortmund,
Germany) using an accelerating voltage of 5 kV and an aperture
size of 20 mm. No metal was deposited on samples before SEM, for
better evidencing embedded nanocrystals. The average fiber
diameter was calculated analyzing at least 100 NFs by an imaging
software (WSxM, Nanotec Electronica, Madrid, Spain) from
various binarized SEM images. Briefly, for each image several
lines, perpendicular to the longitudinal axis of each fiber, were
traced and the diameter was calculated from the resulting signal
intensity vs. position plot. Transmission electron microscopy
(TEM) pictures were obtained using a Jeol Jem 1011 microscope
(JEOL, Tokyo, Japan) operating at an accelerating voltage of
100 kV. The samples were prepared by directly electrospinning on
TEM carbon filmed copper grid with 300 mesh (TAAB
Laboratories Equipment, Aldermaston, England), mounted on
the collector. The presence of nanoparticles and the resulting
chemical composition of NFs mats were analyzed by Fourier-
transform infrared (FTIR) spectroscopy (Spectrum 100, Perkin
Elmer, Waltham, MA) in transmission mode. Spectra were
recorded in the 450–4000 cm
21 range with 256 scans at spectral
resolution of 2 cm
21, averaged and baseline-corrected. A dynamic
mechanical analyzer (DMA Q800, TA Instruments, New Castle,
DE) was employed to perform tensile measurements on the
nanofibrous mats. Each sample (n=5 specimens) was cut into
rectangular shapes (6 mm620 mm), measuring the thickness with
a digital micrometer prior to testing, and subjected to a ramp/rate
of 1 N/min (up to 18 N). Water contact angle analysis (CAM-200
KSV Instruments, Helsinki, Finland) was performed dropping
deionized water (2 ml) from a syringe onto the surface of each
sample (n=5 specimens).
Cell culture
hMSCs were purchased by Lonza (Milan, Italy). A pool of 5
healthy donors was resuspended in Mesenchymal Stem Cell
Growth Medium (MSCGM, Lonza) and cultured in humidified
5% CO2,3 7 uC incubator, removing non adherent cells after 48 h
of incubation. Cells were expanded in vitro until passage 1, and
then seeded onto the nanofibrous and film scaffolds at sub-
confluence density (45000 cells/cm
2). Cell culture on plastic
surface was used as control. Cells were cultured both under basal
(BM) and osteogenic (OM) conditions for two weeks. Osteogenic
medium was purchased by Lonza (Differentiation BulletKit). At
day 7 of culture, some nanofibrous and film scaffolds, cultured in
BM, were processed for SEM. Samples were washed in sodium
cacodylate buffer for 10 min, fixed in 2.5% glutaraldehyde buffer
for 30 min at 4uC, and rinsed twice in cacodylate buffer solution.
Scaffolds were then dehydrated in increasing concentrations of
ethanol, air dried, sputtered with a nano-gold film and analyzed by
SEM (CrossBeam 1540XB, Carl Zeiss, Oberkochen, Germany).
Cell proliferation assay was performed according to AlamarBlue
(Invitrogen, Milan, Italy) instructions, every 24 hours for a week,
in proliferation medium (BM).
ALP activity
ALP enzyme activity of hMSCs, either cultured on NFs or
control film, was assessed after 7 days of cell culture in either basal
or osteogenic medium. ALP staining was performed according to
manufacturer’s instruction (Sigma kit 86-R, Sigma-Aldrich). Cell
culture on plastic surface was used as control. After staining,
samples were digitally photographed, and acquired images were
analyzed using an open source image analysis software (Image J,
NIH). The images were converted in gray-scale (0–255 bit), a
region of interest (ROI) of 41516 px was selected, the mean
Osteoinducting Composite Scaffolds for hMSCs
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each image.
RNA extraction and RT-PCR
mRNA was isolated after 1–2 weeks of culture on plastic or our
materials, either under BM or OM, by using RNAeasy micro kit
(Qiagen, Milan, Italy). Sample amount was determined by
spectrophotometric quantification. All mRNA samples were
treated with deoxyribonuclease I (Invitrogen) prior to reverse
transcription. First strand cDNA synthesis was performed using
equal amount of RNA samples (2 ml), according to M-MLV RT
instructions (Invitrogen). Gene expression levels of core binding
factor alpha 1 (CBFA1/RUNX-2), collagen type 1 (Col-I) and
bone sialoprotein (BSP) were analyzed by real time PCR, using the
Eppendorf Mastercycler ep Realplex2 (Eppendorf, Hamburg,
Germany). Glyceraldehyde 3-phosphate deydrogenase (GAPDH)
was employed as housekeeping gene. Primer sequences and
annealing temperature are reported in Table S1. PCR reactions
were performed using RealMasterMix SYBR Green (5prime,
Hamburg, Germany) in a total volume of 13 ml. Each sample was
assessed at least in duplicate.
Statistical Analysis
For mechanical properties, water contact angle analysis and
ALP staining semi-quantification, a one-way analysis of variance
(ANOVA) with Tukey’s post hoc test for multiple comparisons was
used for statistical analysis (Sigmaplot 12.0, Systat Software Inc.,
Point Richmond, CA), and a P value ,0.05 was considered
statistically significant. Quantitative data on gene expression were
obtained as the mean and standard deviation of values derived
from three independent experiments carried out using cells from
pulled donors. Differences were statistically assessed using Mann-
Whitney non-parametric U-test, and considered statistically
significant with P value ,0.05.
Results and Discussion
Scaffolds characterization
In this study, we demonstrate that a composite nanofibrous
scaffold alone can induce a significant modification of osteogenic
markers, suggesting the induction into osteogenic lineage, of
hMSCs. To evaluate this effect, we fabricated PCL, PCL-HA and
PCL-TCP NFs using the electrospinning technique. In particular,
the average fiber diameter was (2106100) nm, (2306130) nm,
(2256100) nm, for PCL, PCL-HA, and PCL-TCP scaffolds
(Fig. 1A–C), respectively, falling within the range of dimension
characteristic of the ECM architectures [21]. Higher concentra-
tions of nanoparticles in the composite solution unavoidably led to
beads formation due to particles agglomeration, as noted using a
3.5% PCL 4% HA (or TCP) solution (data not shown).
Figure 1. Electron microscopy investigation of electrospun nanofibrous scaffolds. SEM (A–C) and TEM (D–F) micrographs for PCL (A,D),
PCL-HA (B,E) and PCL-TCP (C,F). Bar: 2 mm (A–C), 200 nm (D–F), or 50 nm (insets D–F).
doi:10.1371/journal.pone.0026211.g001
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and PCL-composite fibers (Fig. 1D–F), with the latter displaying a
protruded granulate-like morphology, also observed for HA-
chitosan fibers [28]. Ceramic nanocrystals were present on the
fiber surface as well as embedded in depth, allowing in principle a
slow and constantly growing exposure of ceramic surface to the
cells, while the polymer is degraded. This non-uniform distribution
can be ascribed to the original dispersion, containing both well-
dispersed particles and particle aggregates due to the high viscosity
of the electrospinning solution [27]. While other studies have been
focused on achieving composite fibers by preferentially orienting
the particles parallel to the longitudinal axis of the fibers during the
production [29], or by mineralizing the inorganic phase onto the
organic phase after the realization [30], here the nanoparticles
distribution makes the inorganic phase potentially available for the
cellular microenvironment in a continuous and consistent way.
The chemical composition of the fiber mats, investigated by
FTIR spectroscopy, confirmed the presence of nanoparticles
within the scaffolds. Typical infrared bands for PCL-related
stretching modes were notable for both pure polymer and
composite scaffolds, with the latter showing characteristic PO4
32
absorption bands at 564, 603 and 1031 cm
21 addressable to HA
or TCP nanoparticles (Fig. 2). These peaks were slightly shifted in
respect to standard values for phosphate adsorption bands, which
can be due to the interaction between the ceramic phase with the
polymer phase [33].
The presence of nanoparticles embedded into PCL matrix
affected the mechanical properties of the fiber nets (Fig. 3). While
the elastic modulus values for polymer and composite samples
showed little variation (all falling within the range of 1–6 MPa),
larger differences were reported in ductility. The elongation at
breaking point decreased by the incorporation of ceramic
nanoparticles, as shown for PCL-based composite fibers [33,35].
The amount of the mineral phase was likely not sufficient for
improving mechanical stability, but it played a direct role in chain
polymer entanglements, influencing the ductility properties [25].
Investigating the wettability properties of nanofibrous samples
(Table 1), we found that all formulations had a similar
hydrophobicity behavior with a contact angle in the range 112–
117u, higher than equivalent film samples (69–75u), likely related
to the increased surface roughness at the nanoscale. HA and TCP
nanoparticles are hydrophilic per se, but their embedding can
have no effect on the wettability properties for nanofibrous
composite scaffolds [35]. Though a hydrophilic substrate is often
better than a hydrophobic one for cell culturing, the latter is often
demonstrated able to support a good cell viability, enhancing the
biocompatibility and the subsequent cell growth [38,39].
Cell adhesion and proliferation
Bone cells are greatly sensitive to the chemical-physical
properties of the scaffolds where they are cultured. Surface
composition, roughness, and topography all contribute to the
osteogenic process, being determinants in cell contact, growth,
differentiation and, obviously, cell adhesion represents the initial
phase of cell–scaffold communication, triggering numerous
cellular responses, including proliferation and differentiation
[12,13,40,41]. Here, by loading an equal number of hMSCs onto
film or fibrous samples from different materials (PCL, PCL-HA,
and PCL-TCP), we observed a good cell adhesion and spreading
on all the used scaffold formulations when analyzed by SEM,
although in a qualitative way (Fig. 4). However, we could notice
that on the nanofibrous mats, cells displayed more interaction with
the underlying surface (panel C). Comparable results were
Figure 2. FTIR spectra of electrospun NFs. Typical infrared bands
for PCL-related stretching modes were observed for both the pure
polymeric and composite scaffolds: peaks at 2949 cm
21 (asymmetric
CH2 stretching), 2865 cm
21 (symmetric CH2 stretching), 1727 cm
21
(carbonyl stretching), 1293 cm
21 (C–O and C–C stretching in the
crystalline phase) and 1240 cm
21 (asymmetric COC stretching). For
composite samples characteristic PO4
32 absorption bands attributed to
HA or TCP nanoparticles were observed at 564 cm
21, 603 cm
21, and
1031 cm
21.
doi:10.1371/journal.pone.0026211.g002
Figure 3. Mechanical properties of pure polymeric and composite nanofibrous scaffolds. Results are expressed as mean 6 standard
deviation. Bars show statistically significant differences (P,0.05).
doi:10.1371/journal.pone.0026211.g003
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Therefore, NFs represent a helpful architecture for allowing cell
adhesion. The quantitative in vitro growth of hMSCs, evaluated
through the AlamarBlue assay (graphically displayed in Fig. S1),
showed a similar trend for all materials, without any statistically
significant difference between NFs and controls (films or standard
plastic), independently by their chemical composition. These data
suggest that the nanostructured topography of these scaffolds, as
well as the addition of HA/TCP nanocrystals into the scaffolds,
did not affect cell proliferation over time.
Osteogenic differentiation
Following the osteoblastic differentiation model reported by
Stein and Lian [42], cells largely proliferate up to 7–14 days and
then start to secrete ECM proteins and produce early differenti-
ation markers, such as ALP from day 7. Indeed, ALP is an enzyme
belonging to a group of membrane-bound glycoproteins, involved
in the pathway resulting in the deposition of minerals on ECM
molecules [42]. Therefore, we immuno-histochemically evaluated
the activity of the ALP enzyme for hMSCs cultured for one week
onto samples either in osteogenic (OM) or in basal growth medium
(BM) (Fig. 5). Compared to films, a more evident red staining was
observed on nanofibrous scaffolds, with PCL-TCP scaffolds
slightly showing a more intensive signal in comparison to PCL
and PCL-HA ones (panel A). This result was also confirmed by a
semi-quantitative analysis performed comparing the mean ALP
signal (panel B). When cells were cultured in OM, ALP enzyme
activity was over-expressed, independently by the substrate.
Interestingly, cells cultured onto PCL-HA NFs held a fairly
positive staining for this enzyme also in BM conditions (see Table
S2 for further details).
Since ALP can be expressed by other differentiated cells
[43,44], it is important to study other markers of osteogenic
differentiation as well. To this aim, we performed a quantitative
analysis of mRNA expression levels, focusing on Runt-related
transcription factor 2 (Runx-2), bone sialoprotein (BSP) and type I
collagen (Col-1) genes (Fig. 6). Runx2 strongly influences the
differentiation process of hMSCs into osteogenesis in the early
stage, regulating bone development by G protein-coupled
signaling pathway and promoting an up-regulation of ALP,
osteopontin, osteocalcin and BSP [45]. Runx-2 expression and
activity are usually controlled by external signal, cell-to-cell
interaction and growth regulatory factors [46,47]. Col-1 is
fundamental for the development of the bone cell phenotype,
being correlated to the formation of the ECM. Col-1 is actively
expressed in the first proliferation period and then gradually
down-regulated during subsequent osteoblast differentiation, as
well as other genes (e.g. transforming growth factor-b and
fibronectin) [42]. BSP is a highly sulphated and glycosylated
phosphoprotein found in bone matrix, considered one of the late
markers of mineralized tissue differentiation [48]. Moreover,
elevated mRNA expression levels of BSP in vitro are associated
with the capacity for bone formation by MSCs [49]. In BM
conditions, an almost generalized upregulation of the most typical
osteoblast-related genes occurred over time (7 days vs. 14 days,
Fig. 6A–C), behavior largely independent by the topographic
structure of the scaffolds (NFs vs. films). In particular, type I
collagen displayed a roughly homogeneous expression for all the
conditions, whereas Runx-2 and BSP were statistically and
significantly upregulated over time in all NFs samples. Though
Table 1. Wettability properties of pure polymeric and
composite scaffolds, as spin-coated film and NFs.
Scaffold Contact angle on NFs (6) Contact angle on film (6)
PCL 117627 5 62
PCL-HA 112610.4 6961
PCL-TCP 116617 1 61
Results are expressed as mean 6 standard deviation. Statistically significant
differences (P,0.05) were found for PCL-HA samples.
doi:10.1371/journal.pone.0026211.t001
Figure 4. SEM images of hMSCs cultured on nanofibrous scaffolds and films for 7 days. Cell adhesion onto different scaffolds observed by
SEM. Cells were able to adhere both onto nanofibrous scaffolds (A, C), and control films (B, D). At higher magnification, a single cell is displayed well
attached and spread onto the electrospun NFs, closely associated with the nanofibrous substrate (C). Cells seeded onto control films displayed a less
extensive spreading (D). Images from PCL-HA samples, similar images were obtained by PCL and PCL-TCP samples. Bar: 10 mm (A,B) or 2 mm (C,D).
doi:10.1371/journal.pone.0026211.g004
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vivo, the in vitro differentiation of stem cells, cultured on
nanostructured scaffolds, is generally evaluated only in osteogenic
media, thus suggesting the absence of evident osteoinductive
properties relating to the bare scaffold [23,47,50–52]. Starting
from these bases and our above mentioned results, we compared
the gene expression levels of cells cultured for two weeks either in
basal or osteogenic conditions, in order to evaluate the effect of the
Figure 5. ALP staining. The enzyme activity was evaluated at day 7 of cellular culture onto different samples, either NFs and control films, for each
chemical composition, under BM or OM conditions. A) Both a macroscopic view of the Ø 15 mm disks and an optical microscopic image for each
sample are shown. Bar: 200 mm. B) Semi-quantification of ALP staining: ALP mean intensity values from image analysis of digital micrographs, after
conversion in gray-scale (0–255 bit). Results are reported as mean 6 standard deviation.
doi:10.1371/journal.pone.0026211.g005
Figure 6. Quantitative real time RT-PCR gene expression analysis of some osteoblast-related genes. A–C) Gene expression levels for
hMSCs cultured in basal medium (BM) on different substrates was evaluated over time, comparing results obtained after 7 and 14 days of culture. D–
F) The effect of culture medium on gene expression levels is highlighted comparing results obtained at day 14 for all samples cultured either in BM or
OM. Expression levels of each gene are reported following normalization to averaged levels previously measured at day 1.
doi:10.1371/journal.pone.0026211.g006
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expected, we noticed an almost general, statistically significant
upregulation of Runx-2 and BSP, when cells were cultured with
OM. Collagen type I gene expression levels, on the other side, did
not show an up-regulation comparing BM vs. OM culture media.
This is consistent with the fact that the expression of Col-I,
although essential for osteogenesis during bone formation, is a
basic property of functionally different mesenchymal stem cells
[53]. Interestingly, only by using PCL-TCP NFs as substrate, both
the transcription factor Runx-2 and BSP were equally upregulated
in BM as well as in OM. A slight modification in the expression
levels of several osteogenic genes, including Runx-2, Col-I and
BSP, is reported using a PolyActive
TM–HA–collagen eletrospun
scaffold in basal medium, with no statistically relevant trend of
differentiation [26]. Our results suggest an osteogenic commitment
of hMSCs cultured on PCL-TCP NFs in basal medium, similar to
the results achievable by supplementing growth factors for
directing cell fate towards osteoblast lineage.
Our findings indicate the importance of nanotopography and
materials in mesenchymal cell populations. While the role of
exogenous growth factors as osteogenic commitment regulators is
already demonstrated [54], here we report on the likely coupled
effect of an ECM-like nanostructure and chemical composition of
scaffolds for favoring the differentiation of human stem cells
towards bone lineage. Following a biomimetic approach, we have
successfully developed an osteoinducting nanostructured substrate,
able to mimic a specific physiological microenvironment, finally
priming the natural process of cell differentiation, as results from
the ALP activity and the expression of important genes in the
osteoblast lineage (i.e. Runx-2 and BSP) confirmed. Elucidating
the exact mechanism underlying these results will require future
studies. These will be focused on examining more in depth the
gene expression profile of hMSCs cultured on PCL-TCP
nanofibrous meshes, investigating the regulation of other impor-
tant genes for osteogenesis, such as osteopontin as well as
osteocalcin, osteonectin and bone morphogenetic protein-2.
Moreover, aiming to the use of this kind of materials as a coating
for orthopedic inert implants, we plan to extend the mechanical
investigation to more specific tests (e.g. delamination and abrasion
tests), and, finally, study the effects of NFs-coated implants on bone
regeneration in vivo.
Conclusion
Here we show that scaffold properties play a pivotal role in
controlling the cell growth and impose a direct influence on
intracellular responses and cell fate. Cell adhesion, spreading and
proliferation represent the initial phase of cell–scaffold communi-
cation, which subsequently effect differentiation and mineraliza-
tion. In this study, the effects of scaffold composition and
nanostructured topography were analyzed on cell morphology,
growth and osteogenic differentiation of hMSCs in vitro.
The most basic function of an artificial nanostructured ECM is
to act as a physical substrate for cell attachment and as three-
dimensional microenvironment which serves to organize cells and
provides signals for cellular differentiation and maturation.
Moreover, the presence of an inorganic cue (i.e. TCP nanocrystals)
on the nanofiber surface positively affected differentiation towards
an osteogenic commitment. In conclusion, our results indicate that
composite nanofibers can be offered as a potential bone
regenerative biomaterial for stem cell based therapies.
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Figure S1 Cell proliferation, evaluated by AlamarBlue
assay. The vertical bars show standard deviations.
(TIF)
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for real time RT-PCR.
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Statistically significant differences (P,0.05) are marked by the star.
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